Cannabis Company Khiron Life Sciences Announces Pilot WIth Colombian Health Provider EPS Sura

Khiron Life Sciences Corp. ( (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), has announced that its wholly-owned clinic network, the Latin American Institute of Neurology and the Nervous System (“ILANS”), has partnered with Colombian health insurance company EPS SURA to launch a four-month pilot program that will provide medical services to an initial group of 450 patients. The pilot program, now in progress, represents an initial effort towards an integrated healthcare system for priority neurological pathologies, including convulsive syndrome.

With revenues of approximately $1 billion USD in 2018, EPS SURA is one of the largest health insurance companies in Colombia, and forms part of the wider Suramericana S.A. network across Latin America. The pilot program will allow ILANS to gather patient information and deliver services designed to the individual needs of patients and their families. Further, the launch of the pilot program will leverage both parties’ resources to enhance patient access to integrated healthcare management models, consistent with Khiron’s stated goal to provide effective healthcare options to a population of 620 million individuals in Latin America.

Alvaro Torres, CEO and Director of Khiron, commented: “We are proud to initiate this pilot program with EPS SURA, and for the trust they have placed in ILANS to improve the quality of healthcare management for these initial 450 patients. The program allows us to enhance the patient relationship, and on conclusion, positions us to continue responsibility for their integrated management, including the definition and application of treatment and medical prescriptions and procedures.”

ILANS is one of the most respected, fastest growing, and largest health service network providers in Colombia. The network includes over 60 in-house licensed physicians and clinicians, and services 119,000 patients with strategic locations in target markets, including two  large neurological clinics located in Bogota, Colombia. Khiron is an integrated cannabis company with core operations in Latin America

“This pilot establishes a revenue-generating model for us built around a fixed fee structure, and as we move forward, we anticipate working alongside Latin America’s leading insurance companies to increase the number of patients, and to further expand the application of this integrated care approach.” Says Mr. Torres.